Prospective analysis of the factors influencing the antibody response to hepatitis B vaccine in hemodialysis patients. (Q50976573)

26 March 2018

title

Prospective analysis of the factors influencing the antibody response to hepatitis B vaccine in hemodialysis patients. (English)

1 reference

26 March 2018

0 references

1 reference

1 reference

1 reference

1 reference

Peces R

1

1 reference

26 March 2018

de la Torre M

series ordinal

2

1 reference

26 March 2018

Alcázar R

series ordinal

3

1 reference

26 March 2018

Urra JM

series ordinal

4

1 reference

26 March 2018

publication date

1 February 1997

1 reference

26 March 2018

American Journal of Kidney Diseases

published in

1 reference

26 March 2018

volume

29

1 reference

26 March 2018

issue

2

1 reference

26 March 2018

page(s)

239-245

1 reference

26 March 2018

Immunogenicity of a yeast-derived hepatitis B vaccine in hemodialysis patients

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990036-6

7 January 2021

Genetic prediction of nonresponse to hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990036-6

7 January 2021

Genetic basis of nonresponse to hepatitis B vaccine in hemodialyzed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990036-6

7 January 2021

Poor response to a recombinant hepatitis b vaccine in dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990036-6

7 January 2021

Treatment with recombinant human erythropoietin increases antibody titers after hepatitis B vaccination in dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990036-6

7 January 2021

Recombinant gamma-interferon as adjuvant to hepatitis B vaccine in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990036-6

7 January 2021

HLA-associated non-responsiveness to hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990036-6

7 January 2021

Microdroplet Assay of Human Serum Cytotoxins

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990036-6

7 January 2021

Hepatitis B virus infection in chronic uremia: long-term follow-up of a two-step integrated protocol of vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990036-6

7 January 2021

Comparison of two immunization schedules with recombinant hepatitis B vaccine and natural immunity acquired by hepatitis B infection in dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990036-6

7 January 2021

Relationship between the reactivity to hepatitis B virus vaccination and the frequency of MHC class I, II and III alleles in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990036-6

7 January 2021

Human recombinant erythropoietin directly stimulates B cell immunoglobulin production and proliferation in serum-free medium

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990036-6

7 January 2021

Erythropoietin enhances immunoglobulin production and proliferation by human plasma cells in a serum-free medium

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990036-6

7 January 2021

Effects of recombinant human erythropoietin on HLA sensitization and cell mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990036-6

7 January 2021

The effect of erythropoietin and blood transfusions on highly sensitized patients on a single cadaver renal allograft waiting list

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990036-6

7 January 2021

Influence of HLA-DR phenotype on tumor necrosis factor-alpha production in renal-transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990036-6

7 January 2021

Production of interleukin-6, tumor necrosis factor alpha and interleukin-10 in vitro correlates with the clinical immune defect in chronic hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990036-6

7 January 2021

MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990036-6

7 January 2021

Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). IV. Distinct H-2-linked Ir genes control antibody responses to different HBsAg determinants on the same molecule and map to the I-A and I-C subregions

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990036-6

7 January 2021

Overcoming class II-linked non-responsiveness to hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990036-6

7 January 2021

Selective killing of hepatitis B envelope antigen-specific B cells by class I-restricted, exogenous antigen-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990036-6

7 January 2021

Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990036-6

7 January 2021

T cell activation defect in hemodialysis patients: evidence for a role of the B7/CD28 pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990036-6

7 January 2021

Intracutaneous versus intramuscular hepatitis B vaccination in primary non-responding haemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990036-6

7 January 2021

Low-dose interleukin-2 induces systemic immune responses against HBsAg in immunodeficient non-responders to hepatitis B vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990036-6

7 January 2021

Randomised placebo-controlled trial of recombinant interleukin-2 in chronic uraemic patients who are non-responders to hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990036-6

7 January 2021

10.1016/S0272-6386(97)90036-6

Identifiers

DOI

1 reference

26 March 2018

PubMed ID

9016896

1 reference

26 March 2018